JASON DOMINGUEZ: Open Payments
NPI 1861608424 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,682 in 71 payments from 20 companies in 2025. Trend: 2023 $4,775 · 2024 $2,459 · 2025 $1,682
Food & beverage: $1,483Education: $199
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $329 |
| Regeneron Healthcare Solutions, Inc. | 12 | $236 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $198 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| E.R. Squibb & Sons, L.L.C. | 5 | $83 |
| Lilly USA, LLC | 3 | $81 |
| Galderma Laboratories, L.P. | 4 | $81 |
| GENZYME CORPORATION | 2 | $75 |
| ABBVIE INC. | 3 | $71 |
| Amgen Inc. | 3 | $59 |
Products named: Bimzelx, DUPIXENT, Sotyktu, SKYRIZI, NEMLUVIO, FABRAZYME, COSENTYX, OTEZLA.
Industry payments across TX — which companies pay providers there.
